{
    "2019-08-19": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Stocks To Buy: Is It Time To Buy Or Sell These Large-Cap Stocks?",
                "features": {
                    "keywords": [
                        "stocks",
                        "buy",
                        "sell",
                        "large-cap"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "AbbVie's JAK Inhibitor Rinvoq Receives FDA Approval for RA",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Rinvoq",
                        "FDA",
                        "approval",
                        "RA"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "AbbVie Rises 3%",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "rises"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "5 Biggest New Drug Approvals Potentially on the Way in 2019",
                "features": {
                    "keywords": [
                        "drug",
                        "approvals",
                        "2019"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}